Deri Medical intends to acquire Ningbo Ruiyuan plus in-body diagnostics for 550 million yuan

On the evening of June 1st, Deri Medical announced a restructuring plan, and the company intends to pay a total of 55.4625 million yuan in cash to acquire a 51% stake in Ningbo Ruiyuan Biotech Co., Ltd. ("Ningbo Ruiyuan") held by Zheng Lihong, Yu Youxuan, etc., with its own funds and self-financing funds. At the same time, the company's shares will continue to be suspended due to the need for the company's restructuring-related documents to be reviewed after the fact.according to
, Ningbo Ruiyuan is a bio-high-tech as the core, set research and development, production and sales as one of the in-body diagnostic reagents production enterprises, currently has 117 biochemical reagent products of medical device product registration and annual output of about 100 million ml of liquid biochemical reagents production line, and an annual output of about 200 million ml of liquid biochemical reagents production line will be put into operation in 2015, its products are mainly used for liver function, kidney function, diabetes testing.
financial data, at the end of 2014, Ningbo Ruiyuan had total assets of 154 million yuan and net assets of 143 million yuan, and achieved operating income of 105 million yuan and 117 million yuan, respectively, in 2013 and 2014, with net profit of 34.1249 million yuan and 25.1551 million yuan, respectively. In accordance with the performance commitment, the trading party and Zhang Wen promised that the target company's audited net profit for 2015-2017 would not be less than 42 million yuan, 66 million yuan and 93 million yuan, respectively.
Saidray Medical said that after the completion of the transaction, the company will have a richer product line of bio-diagnostic reagents to further improve the company's revenue structure and achieve sustainable business development, while the two sides will create synergies in management, marketing, research and development, production and supply chain. (Shanghai Securities News, China Securities Network)